Los Angeles, United State: Complete study of the global Primary Progressive Multiple Sclerosis Treatment market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Primary Progressive Multiple Sclerosis Treatment industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Primary Progressive Multiple Sclerosis Treatment production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.
The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global Primary Progressive Multiple Sclerosis Treatment market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the Primary Progressive Multiple Sclerosis Treatment business.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample-form/form/947141/global-primary-progressive-multiple-sclerosis-treatment-industry-market
It is important for every market participant to be familiar with the competitive scenario in the global Primary Progressive Multiple Sclerosis Treatment industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.
Key Players Mentioned in the Global Primary Progressive Multiple Sclerosis Treatment Market Research Report: , F. Hoffmann-La Roche Ltd., Genzyme Corporation, Glialogix, Inc., Kyorin Pharmaceutical Co., Ltd., MedDay SA, Santhera Pharmaceuticals Holding AG, Teva Pharmaceutical Industries Ltd.,
Global Primary Progressive Multiple Sclerosis Treatment Market Segmentation by Product: ApE, Biotin, GZ-402668, Ibudilast, Idebenone, Laquinimod Sodium, Others
Global Primary Progressive Multiple Sclerosis Treatment Market Segmentation by Application: , Hospital, Clinic, Others
The report has classified the global Primary Progressive Multiple Sclerosis Treatment industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Primary Progressive Multiple Sclerosis Treatment manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Primary Progressive Multiple Sclerosis Treatment industry.
Additionally, the industry analysts have studied key regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, along with their respective countries. Here, they have given a clear-cut understanding of the present and future situations of the global Primary Progressive Multiple Sclerosis Treatment industry in key regions. This will help the key players to focus on the lucrative regional markets.
Key questions answered in the report:
Request for customization in Report:https://www.qyresearch.com/customize-request/form/947141/global-primary-progressive-multiple-sclerosis-treatment-industry-market
Table of Content
Table of Contents Executive Summary 1 Primary Progressive Multiple Sclerosis Treatment Market Overview 1.1 Product Overview and Scope of Primary Progressive Multiple Sclerosis Treatment 1.2 Primary Progressive Multiple Sclerosis Treatment Segment by Type 1.2.1 Global Primary Progressive Multiple Sclerosis Treatment Production Growth Rate Comparison by Type (2014-2025) 1.2.2 ApE 1.2.3 Biotin 1.2.4 GZ-402668 1.2.5 Ibudilast 1.2.6 Idebenone 1.2.7 Laquinimod Sodium 1.2.8 Others 1.3 Primary Progressive Multiple Sclerosis Treatment Segment by Application 1.3.1 Primary Progressive Multiple Sclerosis Treatment Consumption Comparison by Application (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.3 Global Primary Progressive Multiple Sclerosis Treatment Market by Region 1.3.1 Global Primary Progressive Multiple Sclerosis Treatment Market Size Region 1.3.2 North America Status and Prospect (2014-2025) 1.3.3 Europe Status and Prospect (2014-2025) 1.3.4 China Status and Prospect (2014-2025) 1.3.5 Japan Status and Prospect (2014-2025) 1.3.6 Southeast Asia Status and Prospect (2014-2025) 1.3.7 India Status and Prospect (2014-2025) 1.4 Global Primary Progressive Multiple Sclerosis Treatment Market Size 1.4.1 Global Primary Progressive Multiple Sclerosis Treatment Revenue (2014-2025) 1.4.2 Global Primary Progressive Multiple Sclerosis Treatment Production (2014-2025) 2 Global Primary Progressive Multiple Sclerosis Treatment Market Competition by Manufacturers 2.1 Global Primary Progressive Multiple Sclerosis Treatment Production Market Share by Manufacturers (2014-2019) 2.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Share by Manufacturers (2014-2019) 2.3 Global Primary Progressive Multiple Sclerosis Treatment Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Primary Progressive Multiple Sclerosis Treatment Production Sites, Area Served, Product Types 2.5 Primary Progressive Multiple Sclerosis Treatment Market Competitive Situation and Trends 2.5.1 Primary Progressive Multiple Sclerosis Treatment Market Concentration Rate 2.5.2 Primary Progressive Multiple Sclerosis Treatment Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Primary Progressive Multiple Sclerosis Treatment Production Market Share by Regions 3.1 Global Primary Progressive Multiple Sclerosis Treatment Production Market Share by Regions 3.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share by Regions (2014-2019) 3.3 Global Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Primary Progressive Multiple Sclerosis Treatment Production 3.4.1 North America Primary Progressive Multiple Sclerosis Treatment Production Growth Rate (2014-2019) 3.4.2 North America Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Primary Progressive Multiple Sclerosis Treatment Production 3.5.1 Europe Primary Progressive Multiple Sclerosis Treatment Production Growth Rate (2014-2019) 3.5.2 Europe Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 3.6 China Primary Progressive Multiple Sclerosis Treatment Production (2014-2019) 3.6.1 China Primary Progressive Multiple Sclerosis Treatment Production Growth Rate (2014-2019) 3.6.2 China Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 3.7 Japan Primary Progressive Multiple Sclerosis Treatment Production (2014-2019) 3.7.1 Japan Primary Progressive Multiple Sclerosis Treatment Production Growth Rate (2014-2019) 3.7.2 Japan Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Primary Progressive Multiple Sclerosis Treatment Consumption by Regions 4.1 Global Primary Progressive Multiple Sclerosis Treatment Consumption by Regions 4.2 North America Primary Progressive Multiple Sclerosis Treatment Consumption (2014-2019) 4.3 Europe Primary Progressive Multiple Sclerosis Treatment Consumption (2014-2019) 4.4 China Primary Progressive Multiple Sclerosis Treatment Consumption (2014-2019) 4.5 Japan Primary Progressive Multiple Sclerosis Treatment Consumption (2014-2019) 5 Global Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price Trend by Type 5.1 Global Primary Progressive Multiple Sclerosis Treatment Production Market Share by Type (2014-2019) 5.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue Market Share by Type (2014-2019) 5.3 Global Primary Progressive Multiple Sclerosis Treatment Price by Type (2014-2019) 5.4 Global Primary Progressive Multiple Sclerosis Treatment Production Growth by Type (2014-2019) 6 Global Primary Progressive Multiple Sclerosis Treatment Market Analysis by Applications 6.1 Global Primary Progressive Multiple Sclerosis Treatment Consumption Market Share by Application (2014-2019) 6.2 Global Primary Progressive Multiple Sclerosis Treatment Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Primary Progressive Multiple Sclerosis Treatment Business 7.1 F. Hoffmann-La Roche Ltd. 7.1.1 F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.1.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.1.3 F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.1.4 Main Business and Markets Served 7.2 Genzyme Corporation 7.2.1 Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.2.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.2.3 Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.2.4 Main Business and Markets Served 7.3 Glialogix, Inc. 7.3.1 Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.3.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.3.3 Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.3.4 Main Business and Markets Served 7.4 Kyorin Pharmaceutical Co., Ltd. 7.4.1 Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.4.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.4.3 Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.4.4 Main Business and Markets Served 7.5 MedDay SA 7.5.1 MedDay SA Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.5.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.5.3 MedDay SA Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.5.4 Main Business and Markets Served 7.6 Santhera Pharmaceuticals Holding AG 7.6.1 Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.6.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.6.3 Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.6.4 Main Business and Markets Served 7.7 Teva Pharmaceutical Industries Ltd. 7.7.1 Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Production Sites and Area Served 7.7.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction, Application and Specification 7.7.3 Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Production, Revenue, Price and Gross Margin (2014-2019) 7.7.4 Main Business and Markets Served 8 Primary Progressive Multiple Sclerosis Treatment Manufacturing Cost Analysis 8.1 Primary Progressive Multiple Sclerosis Treatment Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Primary Progressive Multiple Sclerosis Treatment 8.4 Primary Progressive Multiple Sclerosis Treatment Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.2 Primary Progressive Multiple Sclerosis Treatment Distributors List 9.3 Primary Progressive Multiple Sclerosis Treatment Customers 10 Market Dynamics 10.1 Market Trends 10.2 Opportunities 10.3 Market Drivers 10.4 Challenges 10.5 Influence Factors 11 Global Primary Progressive Multiple Sclerosis Treatment Market Forecast 11.1 Global Primary Progressive Multiple Sclerosis Treatment Production, Revenue Forecast 11.1.1 Global Primary Progressive Multiple Sclerosis Treatment Production Growth Rate Forecast (2019-2025) 11.1.2 Global Primary Progressive Multiple Sclerosis Treatment Revenue and Growth Rate Forecast (2019-2025) 11.1.3 Global Primary Progressive Multiple Sclerosis Treatment Price and Trend Forecast (2019-2025) 11.2 Global Primary Progressive Multiple Sclerosis Treatment Production Forecast by Regions (2019-2025) 11.2.1 North America Primary Progressive Multiple Sclerosis Treatment Production, Revenue Forecast (2019-2025) 11.2.2 Europe Primary Progressive Multiple Sclerosis Treatment Production, Revenue Forecast (2019-2025) 11.2.3 China Primary Progressive Multiple Sclerosis Treatment Production, Revenue Forecast (2019-2025) 11.2.4 Japan Primary Progressive Multiple Sclerosis Treatment Production, Revenue Forecast (2019-2025) 11.3 Global Primary Progressive Multiple Sclerosis Treatment Consumption Forecast by Regions (2019-2025) 11.3.1 North America Primary Progressive Multiple Sclerosis Treatment Consumption Forecast (2019-2025) 11.3.2 Europe Primary Progressive Multiple Sclerosis Treatment Consumption Forecast (2019-2025) 11.3.3 China Primary Progressive Multiple Sclerosis Treatment Consumption Forecast (2019-2025) 11.3.4 Japan Primary Progressive Multiple Sclerosis Treatment Consumption Forecast (2019-2025) 11.4 Global Primary Progressive Multiple Sclerosis Treatment Production, Revenue and Price Forecast by Type (2019-2025) 11.5 Global Primary Progressive Multiple Sclerosis Treatment Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.
- Rally for Multiple Sclerosis Treatment Funding - May 7th, 2011 [May 7th, 2011]
- Breakthrough Multiple Sclerosis Treatment? - May 8th, 2011 [May 8th, 2011]
- Multiple Sclerosis Treatment - Mayo Clinic - May 11th, 2011 [May 11th, 2011]
- Tracy Macchia: Controversial MS Treatment - May 14th, 2011 [May 14th, 2011]
- What is Multiple Sclerosis - May 19th, 2011 [May 19th, 2011]
- MS Multiple Sclerosis treatment testimonial from Sanoviv Medical Institute - May 20th, 2011 [May 20th, 2011]
- Patient with progressive ms(paraplegia) Fmr treatment 1/4 - May 22nd, 2011 [May 22nd, 2011]
- New Jersey Multiple Sclerosis Treatment with Chiropractic Care - May 23rd, 2011 [May 23rd, 2011]
- MS Cure - Progression - June 2nd, 2011 [June 2nd, 2011]
- CCSVI UK Multiple Sclerosis Liberation Treatment - June 2nd, 2011 [June 2nd, 2011]
- Stem Cell Therapy MS: Sam Harrell and The Superbowl - June 3rd, 2011 [June 3rd, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011 - June 8th, 2011 [June 8th, 2011]
- MS treatment sees early success - June 9th, 2011 [June 9th, 2011]
- CCSVI Possible cure for Multiple sclerosis - June 10th, 2011 [June 10th, 2011]
- MS Cure - Introduction to stem cell bone marrow transplant in Australia - June 11th, 2011 [June 11th, 2011]
- (Multiple Sclerosis Cure) Change Your Thinking? (Multiple Sclerosis Cure) - June 12th, 2011 [June 12th, 2011]
- Essiac cancer treatment herbal tincture, Ms Caisse...from The Secrets of Eden - June 12th, 2011 [June 12th, 2011]
- MS walking treatment breakthrough - June 14th, 2011 [June 14th, 2011]
- multiple sclerosis natural treatment | Kathy Canada Testimonial - June 18th, 2011 [June 18th, 2011]
- CCSVI Surgery India - Liberation Procedure Multiple Sclerosis Treatment in India - June 29th, 2011 [June 29th, 2011]
- XCell-Center MS CCSVI Liberation Angioplasty Treatment Results E.Schuurman 18_01_11 - July 1st, 2011 [July 1st, 2011]
- MS Cure - 7PM Project Carmel Turner MS Stem Cell Treatment - July 9th, 2011 [July 9th, 2011]
- MS Update! Tysabri or Gilenya? - July 10th, 2011 [July 10th, 2011]
- What causes BSE, CJD - July 15th, 2011 [July 15th, 2011]
- Kath Bartlett, MS, LAc Balance Method Acupuncture - July 16th, 2011 [July 16th, 2011]
- MS Cure - 730 report ben leahy carmel turner ms stem cell treatment - July 17th, 2011 [July 17th, 2011]
- CCSVI LIberation Treatment Tokuda - July 18th, 2011 [July 18th, 2011]
- FOX News Interview on the O'Reilly Factor - Treatment of Women in Islam - July 18th, 2011 [July 18th, 2011]
- CCSVI treatment bloopers holy crap - July 18th, 2011 [July 18th, 2011]
- Tarah's CCSVI Venoplasty. Dr McGuckin Explaining procedure findings - July 19th, 2011 [July 19th, 2011]
- Cancer Cure: The One-Minute Cure For Cancer, MS - July 24th, 2011 [July 24th, 2011]
- Not Ready to Cheer CCSVI Trials - July 29th, 2011 [July 29th, 2011]
- New Oral Treatment for MS - July 30th, 2011 [July 30th, 2011]
- 27/07/2011 - MS patients seek controversial treatment - August 1st, 2011 [August 1st, 2011]
- MS Cure - 11 I am still walking - August 5th, 2011 [August 5th, 2011]
- Upcoming Treatments for MS - Pt 1 -MSRA Public Lecture - Dr Suzanne Hodgkinson - August 10th, 2011 [August 10th, 2011]
- Stem Cells for MS Community Outreach: Patient Judi Lecoq - Dallas, TX 2011 - August 18th, 2011 [August 18th, 2011]
- Stem Cell Treatment for Multiple Sclerosis - Community Outreach, San Diego: David Oliver - August 19th, 2011 [August 19th, 2011]
- New Study Tests Possible Treatment for MS - August 25th, 2011 [August 25th, 2011]
- Professor Dimitrios Karussis: Treating MS - August 26th, 2011 [August 26th, 2011]
- walking with MS before CCSVI treatment.wmv - August 27th, 2011 [August 27th, 2011]
- Suzy Cohen Discusses The Liberation Treatment for MS - September 14th, 2011 [September 14th, 2011]
- Multiple Sclerosis MS People - Amazing New Treatment - September 15th, 2011 [September 15th, 2011]
- Multiple Sclerosis Alternative Treatment - September 17th, 2011 [September 17th, 2011]
- CLEAR scoliosis treatment, Dr. Culpepper (MS) - September 22nd, 2011 [September 22nd, 2011]
- Liberation treatment for MS - September 23rd, 2011 [September 23rd, 2011]
- 44b - My Lyme disease and rheumatoid arthritis journey - Miraculous CCSVI treatment for MS sufferers - September 24th, 2011 [September 24th, 2011]
- A Closer Look at Gilenya - The First Oral Treatment for MS - September 28th, 2011 [September 28th, 2011]
- Unequal Treatment Drives Disability Rights Movement - September 28th, 2011 [September 28th, 2011]
- Multiple Sclerosis - The Nebraska Medical Center - September 29th, 2011 [September 29th, 2011]
- Testimonial for CCSVI Treatment Excel Heart Center Mexico -- Tanya Reay - September 30th, 2011 [September 30th, 2011]
- Current thinking on what causes MS - Pt 1 - MSRA Public Lecture -Prof Graeme Stewart - October 2nd, 2011 [October 2nd, 2011]
- Current and emerging therapies in MS - Part 02 (How do these treatments work?) - October 2nd, 2011 [October 2nd, 2011]
- MS Richard Humphries before and after treatment for Multiple Sclerosis with stem cells - October 3rd, 2011 [October 3rd, 2011]
- Matthew - CCSVI and his Liberation Treatment - October 8th, 2011 [October 8th, 2011]
- Multiple Sclerosis - Myelin Repair - Video - October 14th, 2011 [October 14th, 2011]
- MS Auto Immune vs CCSVI Treatment Simple Pictures by Berukoff - Video - October 23rd, 2011 [October 23rd, 2011]
- New Promising Treatment for Those Living with Multiple Sclerosis - Video - October 29th, 2011 [October 29th, 2011]
- Stem cells to treat MS - Pt 2 - MSRA Public Lecture - A/Prof Richard Burt - Video - October 30th, 2011 [October 30th, 2011]
- New hope for treating multiple sclerosis - Video - October 31st, 2011 [October 31st, 2011]
- CCSVI Multiple sclerosis Breakthrough/cure - Video - October 31st, 2011 [October 31st, 2011]
- Inhuman Treatment of Wheelchair bound Multiple Sclerosis Patient in Canadian Care Home - Video - November 9th, 2011 [November 9th, 2011]
- MS treatment movie Cells4health.mp4 - Video - November 10th, 2011 [November 10th, 2011]
- Racing to the Cure for MS: Myelin Repair Foundation Celebrates MS Awareness Week - Video - November 12th, 2011 [November 12th, 2011]
- [Symptoms of Multiple Sclerosis] - Video - November 12th, 2011 [November 12th, 2011]
- Multiple Sclerosis Treated with Adult Stem Cells - Video - November 13th, 2011 [November 13th, 2011]
- Stem cells to treat MS - Pt 1 - MSRA Public Lecture - A/Prof Richard Burt - Video - November 16th, 2011 [November 16th, 2011]
- Multiple Sclerosis A Natural Treatment - Video - November 16th, 2011 [November 16th, 2011]
- My MS and Stem Cell Treatment - Video - November 16th, 2011 [November 16th, 2011]
- CCSVI Liberation News Reports - Video - November 20th, 2011 [November 20th, 2011]
- Stem Cells for MS Community Outreach: Patient Sam Harrell - Dallas, TX 2011 - Video - November 21st, 2011 [November 21st, 2011]
- Arthur S13 E2-1 - The Silent Treatment - Video - November 27th, 2011 [November 27th, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach San Diego CA - Video - December 3rd, 2011 [December 3rd, 2011]
- CCSVI - Video - December 3rd, 2011 [December 3rd, 2011]
- My Sister's Experience with Liberation Treatment for Multiple Sclerosis PART 2/2 - Video - December 5th, 2011 [December 5th, 2011]
- Multiple Sclerosis -- Treatment LDN story - Video - December 7th, 2011 [December 7th, 2011]
- ABC News - Multiple Sclerosis effectively treated by a new acoustic medical device. - Video - December 9th, 2011 [December 9th, 2011]
- MS Patient After Stem Cell Therapy - Video - December 10th, 2011 [December 10th, 2011]
- Multiple Sclerosis - Video - December 12th, 2011 [December 12th, 2011]
- Journey of Connective Tissue, Autoimmune disease, steroid treatment updates. - Video - December 22nd, 2011 [December 22nd, 2011]